Ani Pharmaceuticals Report issue

Contributed to NME For profit Phase 3
Founded: Baudette MN United States (2004)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2004
promethazine hydrochloride (phenergan)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ANI PHARMS | ANI PHARMS INC | APPLIED ANAL